Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Meningitis, Meningococcal, Date of authorisation: 24/05/2017, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B vaccine (recombinant, component, adsorbed), Meningitis, Meningococcal, Date of authorisation: 13/01/2013, Revision: 22, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587201 ◽

2019 ◽

Author(s):

Keyword(s):

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group B

Download Full-text

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Meningitis, Meningococcal, Date of authorisation: 24/05/2017, Revision: 5, Status: Authorised

Case Medical Research ◽

10.31525/cmr-67956d ◽

2019 ◽

Author(s):

Keyword(s):

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group B

Download Full-text

Human medicines European public assessment report (EPAR): Bexsero, meningococcal group-B vaccine (rDNA, component, adsorbed), Meningitis, Meningococcal, Date of authorisation: 13/01/2013, Revision: 20, Status: Authorised

Case Medical Research ◽

10.31525/cmr-56e4ac ◽

2019 ◽

Author(s):

Keyword(s):

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group B

Download Full-text

Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Immunization,Meningitis, Meningococcal, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 28, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c3f2ac ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal group A, C, W 135 and Y conjugate vaccine, Meningitis, Meningococcal, Date of authorisation: 20/04/2012, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-913577 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal group A, C, W 135 and Y conjugate vaccine, Meningitis, Meningococcal, Date of authorisation: 20/04/2012, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-908f20 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Immunization,Meningitis, Meningococcal, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c4dbb1 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Condylomata Acuminata,Papillomavirus Infections,Immunization,Uterine Cervical Dysplasia, Date of authorisation: 09/06/2015, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d7cc26 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Papillomavirus Infections ◽

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Herpes Zoster, Date of authorisation: 21/03/2018, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1ad6fa9 ◽

2019 ◽

Author(s):

Keyword(s):

Herpes Zoster ◽

Vaccine Recombinant ◽

Zoster Vaccine ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Condylomata Acuminata,Papillomavirus Infections,Immunization,Uterine Cervical Dysplasia, Date of authorisation: 09/06/2015, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d82021 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Papillomavirus Infections ◽

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Uterine Cervical Dysplasia

Download Full-text